Search company, investor...

Everist Genomics

everistgenomics.com

Founded Year

2001

Stage

Series A | Alive

Total Raised

$4.88M

Last Raised

$3.06M | 10 yrs ago

About Everist Genomics

Provider and developer of diagnostics, prognostics, and therapeutic selection technologies. The company's focus is on diseases including cancer, cardiovascular disease, and metabolic disease, such as diabetes. The products integrate with mobile digital services, smartphones, and tablet computers. [Keywords: personalized medicine, oncology, drug rescue, companion diagnostics]

Headquarters Location

709 West Ellsworth Road

Ann Arbor, Michigan, 48108,

United States

(734)929-9475

Missing: Everist Genomics's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Everist Genomics's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Expert Collections containing Everist Genomics

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Everist Genomics is included in 2 Expert Collections, including Diabetes.

D

Diabetes

1,899 items

B

Biopharma Tech

15,535 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.

Everist Genomics Frequently Asked Questions (FAQ)

  • When was Everist Genomics founded?

    Everist Genomics was founded in 2001.

  • Where is Everist Genomics's headquarters?

    Everist Genomics's headquarters is located at 709 West Ellsworth Road, Ann Arbor.

  • What is Everist Genomics's latest funding round?

    Everist Genomics's latest funding round is Series A.

  • How much did Everist Genomics raise?

    Everist Genomics raised a total of $4.88M.

  • Who are the investors of Everist Genomics?

    Investors of Everist Genomics include CrystalPoint Partners.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.